Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study

BACKGROUND: The utility of the Simplified Psoriasis Index (SPI), a recently developed multidomain tool for assessing psoriasis, was investigated in a study assessing response to secukinumab. METHODS: In an open‐label, multicentre study involving 17 French centres, patients with moderate‐to‐severe pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Richard, M.‐A., Lacour, J.‐P., Konstantinou, M.‐P., Ruer‐Mulard, M., Joly, P., Aractingi, S., Auquier, P., Pelvet, B., Augustin, M.L., Mahé, E., Chalmers, R.J.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Psoriasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984225/
https://www.ncbi.nlm.nih.gov/pubmed/32815591
http://dx.doi.org/10.1111/jdv.16893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984225/
https://www.ncbi.nlm.nih.gov/pubmed/32815591
http://dx.doi.org/10.1111/jdv.16893

Ejemplares similares